Shares of Blue Jet Healthcare Ltd. debuted at Rs 380 apiece on the NSE, a premium of 9.83% to their IPO price of Rs 346 apiece.
On the Bombay Stock Exchange, the shares listed at Rs 359.90 apiece, a premium of 4.02%.
The shares ended at a premium of 14.41% over the IPO price, and advanced 9.99% from its listing price to end at Rs 395.85 apiece.
The Rs 840.3 crore IPO was subscribed to 7.94 times on its final day. Bids were led by institutional investors (13.72 times), non-institutional investors (13.59 times), and retail investors (2.22 times).
Business
Blue Jet Healthcare is a specialty pharmaceutical and healthcare ingredients and intermediates company, offering niche products targeted towards innovator pharmaceutical companies and multi-national generic pharmaceutical companies.
The company's operations are primarily organised in three product categories:
Contrast media intermediates.
High-intensity sweeteners.
Pharma intermediates and active pharmaceutical ingredients
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
